Discontinued — last reported Q1 '25
Business Segments · Other
U.S. Pharmaceutical — Other
Analysis
StatementSegment
CategoryOther
SignalContext dependent
VolatilityModerate
First reportedQ1 2020
Last reportedQ1 2025Aug 7, 2024
Rolls up toForeign exchange and other
How to read this metric
Large or frequent values may indicate volatility in non-core operational activities.
Detailed definition
Residual items or miscellaneous financial activities within the U.S. pharmaceutical segment that do not qualify for spec...
Peer comparison
Standard catch-all for segment-level reporting.
Metric ID:
mck_segment_u_s_pharmaceutical_otherHistorical Data
11 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | -$7.00M | -$1.00M | $1.00M | $0.00 | $0.00 | $5.00M | $0.00 | -$1.00M |
| QoQ Change | — | — | — | — | +85.7% | +200.0% | -100.0% | — | — | -100.0% | — |
| YoY Change | — | — | — | — | — | +114.3% | +100.0% | — | — | -100.0% | — |
Range-$7.00M – $5.00M
Avg YoY Growth+38.1%
Median YoY Growth+100.0%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is McKesson's u.s. pharmaceutical — other?
- McKesson (MCK) reported u.s. pharmaceutical — other of -$1.00M in Q2 2024.
- What does u.s. pharmaceutical — other mean?
- Miscellaneous financial items for the U.S. pharmaceutical segment.